Haem - transfusion Flashcards

1
Q

What are the ABO and Rhesus blood group systems?

A

They are examples of and the most important groups of RBC surface antigens which identify the RBC to the immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many RBC antigen systems are there and what are these antigens

A

At least 30

The antigens are polypeptides, polysaccharides or glycoproteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name the minor blood group systems

A
Kell
MNS
Lewis
P
Duffy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the H antigen

A

All patient’s RBC’s have a ‘core antigen’ called the H antigen. The H antigen is a disaccharide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the ABO system

A

Group O
- the patient’s only express the H antigen. O signifies no other sugars are added

Group A
- Additional CHO group N - acetylgalactosamine is bound to H antigen making a trisaccharide = The A antigen

Group B
- D-glacatose is bound to the H-antigen –> making a trisaccharide = the B-antigen

Group AB
- These patients express both A and B antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the Rhesus blood group named after

A

The Rhesus monkey, the animal whose blood was used in discovery of the Rhesus system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How many different Rhesus antigens are there and which are the most important. Which rhesus antigen is present when patients are referred to as Rhesus positive?

A

50

Most NB
D
C
c
E
e

D is most NB. This is the antigen present in patient’s who are referred to as Rhesus positive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the Rhesus D antigen

A

A large (30 Da) cell membrane protein, thought to be a subunit of the NH3 transport protein. Genetics determine the presence of this Ag on the RBC surface.

85% population are Rhesus D positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What percentage of population is Rhesus negative

A

± 15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why does the immune system develop antibodies to non-self red cell antigens

A
  1. Exposure to foreign RBCs
    - Placental abruption
    - Blood transfusion
  2. Exposure to environmental antigens (e.g. food / bacteria) –> may be similar to nonself RBC Ag with cross reaction.

Antigen Presenting Cells (APCs) present foreign material to the immune system which then develops antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

At what age are non-self ABO Ag present in the plasma. What antibodies are produced by each blood group

A

From 6 months onwards (environmental Ag that have a similar chemical structure to ABO Ags)

Group O - Anti A and Anti B
Group A - Anti B
Group B - Anti A
Group AB - none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What type of antibodies are Anti A and Anti B and why is this important.

A

IgM

This is important as IgM is unable to cross the placenta –> if it could every fetus of different blood group to the mother would have its RBCs attacked by maternal immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does the development of non-self antibodies differ between the ABO blood group system and the Rhesus blood group system

A

The 15% of the population who are RhD negative DO NOT naturally develop RhD antibodies. Anti-RhD antibodies are only acquired on exposure to foreign RBCs carrying the RhD Ag.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When can exposure to the RhD antigen occur (i.e. in a Rh negative patient)

A
  1. incompatible blood transfusion - RhD pos blood into RhD neg patient
  2. Fetal-maternal haemorrhage
    - After childbirth/abortion/trauma/placental abruption
    - If Rh pos fetus and Rh neg mom –> the maternal immune system will then develop anti-RhD antibodies which are IgG and are able to cross the placenta
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What type of Antibodies are Anti-RhD and why is this important

A

IgG

This is important as these antibodies DO cross the placenta. Current and future fetuses can develop haemolysis and severe anaemia and if they survive to term will be born with haemolytic disease of the newborn.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is RhoGAM?

A

“rhod Immune globulin human”

This is anti-RhD immunglobulin given to mothers once or twice during pregnancy and at birth in an attempt to prevent maternal sensitization to RhD.

The parenteral anti-RhD IgG binds and removes any fetal RBCs which pass into the maternal circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is allogenic versus autologous blood transfusion?

A

Allogenic - donor blood (usually packed red cells) is given intravenously to a recipient

Autologous blood transfusion is where blood is taken from a patient and re-infused back into the same patient when required.
Examples:
1. Intra-operative cell salvage
2. Preoperative autologous blood donation
3. Acute normovolaemic haemodilution

18
Q

Give three examples of autologous blood transfusion

A

Examples:

  1. Intra-operative cell salvage
  2. Preoperative autologous blood donation
  3. Acute normovolaemic haemodilution
19
Q

When will a haemolytic transfusion reaction occur. What is the mechanism of this?

A

When the recipients blood contains antibodies to the donor’s RBC antigens.

Recipient antibodies coat the donor RBCs. The Ab-Ag complex activates the complement cascade –> haemolysis of donor RBCs.

20
Q

What are the two types of haemolytic transfusion reactions. Describe and differentiate these types.

A

IMMEDIATE (within 24 hours) –> usually first 6 hours

  • ABO
  • Complement
  • Intravascular haemolysis
  • Severity depends on Ab titre
  • Clinically: Uritcaria / flushing / chest pain / dyspnoea / jaundice / tachycardia / shock / Hburia / DIC
  • If RhD –> extravascular haemolysis + less severe

DELAYED (After 24 hours –> usually 7 - 21 days up to 30 days)

  • Minor RhD antigens and the minor blood group systems (Kell, Lews, MNS, P and Duffy)
  • Ag exposure –> secondary immune response –> formation of IgG (which takes a few days –> hence the delay.
21
Q

Why is delayed haemolytic reaction ‘delayed’

A

Exposure of patient blood/immune system to minor blood group antigens elicits a secondary immune response with the production of IgG antibodies. Therefore, there is a delay as the antibodies take time to be made

22
Q

Define Universal Donor and universal recipient

A

Donor: Group: O negative

Recipient: AB positive

23
Q

What is a cross match? What are the different types of cross match that can be performed

A

Compatibility test between donor and recipient blood

Major cross match
- Donor RBCs mixed with recipient plasma –> if clumping then blood is incompatible

Minor cross match
- Recipient RBCs mixed with donor plasma

24
Q

Why is minor cross match no longer frequently performed

A

RBCs are now transfused as packed cells and thus contain an insignificant amount of donor plasma.

Minor cross match = recipient RBCs with donor plasma

25
Q

How are Packed RBCs made and stored

A
  1. Cetrifuged whole blood –> plasma removed
  2. RBCs resuspended in minimum amount of fluid Hct > 75%
  3. Citrate, Adenine and glucose added
  4. Storage at 4 degrees
  5. Shelf life 42 days
26
Q

What changes occur to RBCs during storage

A
  1. Some become spherical (reduced life span)
  2. K+ rises to 30 mmol/L by 28 days
  3. ATP levels fall
  4. 2.3-DPG fall (after transfusion it takes 24 hours for 2,3-DPG levels to return to normal)
27
Q

How long does it take 2,3 DPG levels to return to normal after a unit of packed red blood cells is transfused and what theoretical and clinical implications of this are there

A

24 hours.

Low 2,3-DPG means Hb in relaxed state with higher affinity for O2 than native Hb. This means it is less likely to offload the O2 to the tissues (The P50 of the OHDC is shifted to the left).

It is still unclear if this has any clinical/practical implications with regards to O2 delivery in the patient immediately after a blood transfusion.

28
Q

What is FFP. How is it produced and stored? What is FFP shelf life

A

Fresh Frozen Plasma.

This is the plasma removed from whole blood during the process of producing packed RBCs.

Storage
1. Cooled to -30 deg C within 8 hours of donation

Shelf life
1. 1 year

29
Q

What is FFP used for

A
  1. To replace coagulation factors

2. To derive other blood products

30
Q

What other products can be produced from FFPs. Describe these products

A
  1. Cryoprecipitate
    - FFPs to -70 deg C –> thawed + centrifuged –> precipitate collected
    - Rich in factors: Fibrinogen (1), 8, vWF, 13
  2. Freeze-dried factor 8 concentrate
    - small amount of fibrinogen
    - used in haemophilia A
  3. Freeze-dried factor 9 concentrate
    - small amount: fibrinogen, 2, 7, 10
    - Used in Christmas disease (Haemophilia B - IX deficient)
31
Q

How are platelets produced

A

Either pooled platelets or from multiple donors or collected from one donor.

Process is apheresis (machine)

32
Q

How is risk of infectious disease in platelets mitigated

A

Ultraviolet irradiated

33
Q

How are platelets stored? What is their shelf life

A

At room temperature –> become non-functional at 4 deg C.

shelf life: 5 days

34
Q

Can platelets be transfused without cross match

A

Yes but the platelet count rises more if they are ABO type specific

35
Q

What is cell salvage

A

Method of autologous blood transfusion: patient’s own blood is collected, processed, stored and re-transfused

NB to reduce need for allogenic transfusion

Red cells are collected from surgical field then centrifuged, washed and resuspended in saline

36
Q

What are the advantages and disadvantages of cell salvage?

A

Advantages

  • More cost effective
  • No infective / immune risk
  • Accepted by some Jehovahs witnesses

Disadvantages

  • Electrolyte abnormalities (esp. in massive t/f)
  • Clotting factors lost –> dilutional coagulopathy
  • Precipitate amnioitic fluid embolus (not completely removed by washing process)
  • Cancer cells
37
Q

How can the risk of precipitating amniotic fluid embolus / cancer cell reinfusion with cell salvage be reduced and considered safe

A

Combining cell salvage with a leucocyte depletion filter

38
Q

What is a massive transfusion

A

Transfusion of more than the patients circulating blood volume < 24 hours

OR

Transfusion of more than half patient’s blood volume in < 4 hours

39
Q

What are the additional risks conferred by MASSIVE transfusion

A
  1. Hypothermia (causing: coagulalopathy / arrhythmia / Left OHDC)
  2. Dilutional coagulopathy
  3. Hypocalcaemia (citrate)
  4. Hyperkalaemia (K = 30 mmol/L at day 28)
  5. Acidosis (pH 6.8) –> lactate accumulation due to anaerobic metabolism of RBCs during storage
40
Q

What is the role of citrate in stored blood

A

To chelate Ca++ to prevent coagulation of stored blood

41
Q

What are the alternatives to using blood for O2 carriage?

A
  1. Hb-based O2 carriers
    - Hb cross linked polymerized and encapsulated (Hb alone causes renal tubular damage)
  2. Perfluorocarbon based O2 carriers
42
Q

What are the advantages to using O2 carrying blood substitutes over human blood

A
  1. Infection/immune complications
  2. Longer shelf life
  3. Stored at ambient temp
  4. Acceptable to Jehovah’s witnesses